3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
2
Conditions
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Neoplasms
1
Hodgkin Disease
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
ivosidenib
2
Vemurafenib
2
Triptorelin Pamoate
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Drug Therapy
2
surufatinib
1
olaparib
1
larotrectinib
1
fludarabine
1
erdafitinib
1
ensartinib
1
copanlisib
1
bempegaldesleukin
1
Zoledronic Acid
1
Stem Cell Transplantation
1
Sirolimus
1
Proton Therapy
1
Pharmacogenomic Variants
1
Nivolumab
1
Methionine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Triptorelin Pamoate
×
Lymphoid
×
Clear all
NCT05328258
2023-10-27
ProFertil
Karolinska University Hospital
Phase 3
Recruiting
500 enrolled
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled